Sirolimus May Promote Thrombotic Microangiopathy
Open Access
- 1 February 2003
- journal article
- case report
- Published by Elsevier in American Journal of Transplantation
- Vol. 3 (2) , 229-230
- https://doi.org/10.1034/j.1600-6143.2003.00018.x
Abstract
Click on the article title to read more.Keywords
This publication has 6 references indexed in Scilit:
- SIROLIMUS (RAPAMYCIN) FOR THE TREATMENT OF STEROID-REFRACTORY ACUTE GRAFT-VERSUS-HOST DISEASE1Transplantation, 2001
- De novo hemolytic uremic syndrome after kidney transplantation in patients treated with cyclosporine a sirolimus combinationTransplantation Proceedings, 2001
- A WORLDWIDE, PHASE III, RANDOMIZED, CONTROLLED, SAFETY AND EFFICACY STUDY OF A SIROLIMUS/CYCLOSPORINE REGIMEN FOR PREVENTION OF ACUTE REJECTION IN RECIPIENTS OF PRIMARY MISMATCHED RENAL ALLOGRAFTSTransplantation, 2001
- Systemic Toxicity Following Administration of Sirolimus (Formerly Rapamycin) for PsoriasisArchives of Dermatology, 1999
- Enhancement of human platelet aggregation and secretion induced by rapamycinNephrology Dialysis Transplantation, 1998
- Comparison of the effect of rapamycin and FK506 on release of prostacyclin and endothelin in vitroClinical Biochemistry, 1993